Drug developers can bridge the gap between molecule discovery and dose form selection with the process called Parallel Screening. Discover how this method is the most efficient way of maximizing a NCE's chances of making it to Phase 1. Glean insight on the critical importance of pre-formulation characterization early on in the drug development journey and more. |